ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
Zenox
|
386 |
163K |
3 |
07/04/23 |
07/04/23 |
ASX - By Stock
|
386
|
163K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
3 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
Zenox
|
386 |
163K |
5 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
386
|
163K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
Zenox
|
386 |
163K |
20 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
386
|
163K
|
20
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
9 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Zenox
|
139 |
63K |
39 |
02/04/23 |
02/04/23 |
ASX - By Stock
|
139
|
63K
|
39
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
Zenox
|
559 |
182K |
5 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
559
|
182K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: NWR Virtual Healthcare Conference Presentation
|
|
Zenox
|
88 |
28K |
6 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
88
|
28K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: NWR Virtual Healthcare Conference Presentation
|
|
Zenox
|
88 |
28K |
0 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
88
|
28K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
MOZZ OARSI 2023 - NOTES
|
|
Zenox
|
79 |
33K |
19 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
79
|
33K
|
19
|
|
ASX - By Stock
|
PAR |
Re:
MOZZ OARSI 2023 - NOTES
|
|
Zenox
|
79 |
33K |
16 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
79
|
33K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
MOZZ OARSI 2023 - NOTES
|
|
Zenox
|
79 |
33K |
21 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
79
|
33K
|
21
|
|
ASX - By Stock
|
PAR |
Re:
The rumours are true - I'm going...
|
|
Zenox
|
108 |
52K |
15 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
108
|
52K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
5 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
10 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Zenox
|
1.0K |
391K |
2 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Zenox
|
1.0K |
391K |
5 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Zenox
|
1.0K |
391K |
2 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Zenox
|
1.0K |
391K |
4 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Zenox
|
1.0K |
391K |
1 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Zenox
|
1.0K |
391K |
0 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Zenox
|
1.0K |
391K |
1 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
9 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
5 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
3 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
9 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Zenox
|
4.2K |
3.8M |
3 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
2 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
7 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
7
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
6 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Zenox
|
4.1K |
1.9M |
1 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
5 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
141
|
56K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
4 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
141
|
56K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
23 |
11/12/22 |
11/12/22 |
ASX - By Stock
|
141
|
56K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
0 |
11/12/22 |
11/12/22 |
ASX - By Stock
|
141
|
56K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Zenox
|
670 |
255K |
9 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
670
|
255K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
6 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
141
|
56K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
5 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
141
|
56K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
11 |
03/12/22 |
03/12/22 |
ASX - By Stock
|
141
|
56K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
11 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
141
|
56K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
2 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
141
|
56K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
2 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
141
|
56K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
2 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
141
|
56K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
1 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
141
|
56K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
Zenox
|
141 |
56K |
1 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
141
|
56K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
Zenox
|
213 |
74K |
2 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
213
|
74K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
Zenox
|
213 |
74K |
5 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
213
|
74K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
Zenox
|
213 |
74K |
5 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
213
|
74K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
Zenox
|
213 |
74K |
5 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
213
|
74K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
Zenox
|
213 |
74K |
3 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
213
|
74K
|
3
|
|